Produkty lecznicze - Wykaz pozwoleń na dopuszczenie do obrotu udzielonych przez państwa EFTA należące do EOG w pierwszym półroczu 2016 r.
Dz.U.UE.C.2017.58.10
Akt nienormatywnyProdukty lecznicze - Wykaz pozwoleń na dopuszczenie do obrotu udzielonych przez państwa EFTA należące do EOG w pierwszym półroczu 2016 r.
(Dz.U.UE C z dnia 23 lutego 2017 r.)
Podkomitet I ds. Swobodnego Przepływu Towarów
Do wiadomości Wspólnego Komitetu EOG
W nawiązaniu do decyzji Wspólnego Komitetu EOG nr 74/1999 z dnia 28 maja 1999 r. Wspólnemu Komitetowi EOG przekazuje się celem przyjęcia do wiadomości na posiedzeniu w dniu 28 października 2016 r. następujące wykazy dotyczące pozwoleń na dopuszczenie do obrotu produktów leczniczych za okres od dnia 1 stycznia do dnia 30 czerwca 2016 r.:
Załącznik I Wykaz nowych pozwoleń na dopuszczenie do obrotu
Załącznik II Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
Załącznik III Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
Załącznik IV Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
Załącznik V Wykaz zawieszonych pozwoleń na dopuszczenie do obrotu
ZAŁĄCZNIKI
ZAŁĄCZNIK I
Wykaz nowych pozwoleń na dopuszczenie do obrotu
Wykaz nowych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data udzielenia zezwolenia |
EU/1/15/1053 | Neofordex | Liechtenstein | 30.4.2016 |
EU/1/15/1053 | Neofordex | Islandia | 31.3.2016 |
EU/1/15/1053 | Neofordex | Norwegia | 1.4.2016 |
EU/1/15/1063 | Pemetrexed Actavis | Liechtenstein | 29.2.2016 |
EU/1/15/1063 | Pemetrexed Actavis | Norwegia | 25.1.2016 |
EU/1/15/1063 | Pemetrexed Actavis | Islandia | 25.1.2016 |
EU/1/15/1064 | Imlygic | Liechtenstein | 29.2.2016 |
EU/1/15/1064 | Imlygic | Norwegia | 20.1.2016 |
EU/1/15/1064 | Imlygic | Islandia | 14.1.2016 |
EU/1/15/1065 | Eptifibatid Accord | Liechtenstein | 29.2.2016 |
EU/1/15/1065 | Eptifibatide Accord | Norwegia | 18.1.2016 |
EU/1/15/1065 | Eptifibatide Accord | Islandia | 14.1.2016 |
EU/1/15/1066 | Ongentys | Liechtenstein | 30.6.2016 |
EU/1/15/1067 | Lopinavir/Ritonavir Mylan | Liechtenstein | 29.2.2016 |
EU/1/15/1067 | Lopinavir/Ritonavir Mylan | Norwegia | 21.1.2016 |
EU/1/15/1067 | Lopinavir/Ritonavir Mylan | Islandia | 20.1.2016 |
EU/1/15/1068 | Wakix | Liechtenstein | 30.4.2016 |
EU/1/15/1068 | Wakix | Norwegia | 19.4.2016 |
EU/1/15/1068 | WAKIX | Islandia | 22.4.2016 |
EU/1/15/1069 | Episalvan | Liechtenstein | 29.2.2016 |
EU/1/15/1069 | Episalvan | Norwegia | 20.1.2016 |
EU/1/15/1069 | Episalvan | Islandia | 19.1.2016 |
EU/1/15/1070 | Oncaspar | Liechtenstein | 29.2.2016 |
EU/1/15/1070 | Oncaspar | Norwegia | 25.1.2016 |
EU/1/15/1070 | Oncaspar | Islandia | 25.1.2016 |
EU/1/15/1071 | Pemetrexed Accord | Liechtenstein | 29.2.2016 |
EU/1/15/1071 | Pemetrexed Accord | Norwegia | 25.1.2016 |
EU/1/15/1071 | Pemetrexed Accord | Islandia | 25.1.2016 |
EU/1/15/1072 | Spectrila | Liechtenstein | 29.2.2016 |
EU/1/15/1072 | Spectrila | Norwegia | 19.1.2016 |
EU/1/15/1072 | Spectrila | Islandia | 19.1.2016 |
EU/1/15/1073 | Briviact | Liechtenstein | 29.2.2016 |
EU/1/15/1073 | Briviact | Norwegia | 21.1.2016 |
EU/1/15/1073 | Briviact | Islandia | 25.1.2016 |
EU/1/15/1074 | Benepali | Liechtenstein | 29.2.2016 |
EU/1/15/1074 | Benepali | Norwegia | 19.1.2016 |
EU/1/15/1074 | Benepali | Islandia | 19.1.2016 |
EU/1/15/1075 | Feraccru | Liechtenstein | 29.2.2016 |
EU/1/15/1075 | Feraccru | Norwegia | 7.3.2016 |
EU/1/15/1075 | Feraccru | Islandia | 18.3.2016 |
EU/1/15/1076 | Kovaltry | Liechtenstein | 29.2.2016 |
EU/1/15/1076 | Kovaltry | Norwegia | 10.3.2016 |
EU/1/15/1076 | Kovaltry | Islandia | 16.3.2016 |
EU/1/15/1077 | Iblias | Liechtenstein | 29.2.2016 |
EU/1/15/1077 | Iblias | Norwegia | 10.3.2016 |
EU/1/15/1077 | Iblias | Islandia | 16.3.2016 |
EU/1/15/1079 | Vaxelis | Liechtenstein | 29.2.2016 |
EU/1/15/1079 | Vaxelis | Norwegia | 29.2.2016 |
EU/1/15/1079 | VAXELIS | Islandia | 1.3.2016 |
EU/1/15/1080 | Zurampic | Liechtenstein | 29.2.2016 |
EU/1/15/1080 | Zurampic | Norwegia | 3.3.2016 |
EU/1/15/1080 | Zurampic | Islandia | 16.3.2016 |
EU/1/15/1081 | Caspofungin Accord | Liechtenstein | 29.2.2016 |
EU/1/15/1081 | Caspofungin Accord | Norwegia | 29.2.2016 |
EU/1/15/1081 | Caspofungin Accord | Islandia | 25.2.2016 |
EU/1/15/1082 | Galafold | Liechtenstein | 30.6.2016 |
EU/1/15/1082 | Galafold | Norwegia | 14.6.2016 |
EU/1/15/1082 | Galafold | Islandia | 14.6.2016 |
EU/1/15/1083 | Uptravi | Liechtenstein | 30.6.2016 |
EU/1/15/1083 | Uptravi | Islandia | 26.5.2016 |
EU/1/15/1083 | Uptravi | Norwegia | 30.5.2016 |
EU/1/15/1084 | Portrazza | Liechtenstein | 29.2.2016 |
EU/1/15/1084 | Portrazza | Norwegia | 26.2.2016 |
EU/1/15/1084 | Portrazza | Islandia | 15.3.2016 |
EU/1/15/1085 | Taltz | Liechtenstein | 30.4.2016 |
EU/1/15/1085 | Taltz | Norwegia | 9.5.2016 |
EU/1/15/1085 | Taltz | Islandia | 20.5.2016 |
EU/1/16/1086 | TAGRISSO | Liechtenstein | 29.2.2016 |
EU/1/16/1086 | Tagrisso | Norwegia | 19.2.2016 |
EU/1/16/1086 | Tagrisso | Islandia | 11.2.2016 |
EU/1/16/1087 | Coagadex | Liechtenstein | 30.4.2016 |
EU/1/16/1087 | Coagadex | Norwegia | 1.4.2016 |
EU/1/16/1087 | Coagadex | Islandia | 22.3.2016 |
EU/1/16/1088 | Empliciti | Liechtenstein | 30.6.2016 |
EU/1/16/1088 | Empliciti | Norwegia | 24.5.2016 |
EU/1/16/1088 | Empliciti | Islandia | 19.5.2016 |
EU/1/16/1089 | Pandemic influenza vaccine H5N1 MedImmune | Liechtenstein | 30.6.2016 |
EU/1/16/1089 | Pandemic influenza vaccine H5N1 MedImmune | Norwegia | 30.5.2016 |
EU/1/16/1089 | Pandemic influenza vaccine H5N1 MedImmune | Islandia | 30.5.2016 |
EU/1/16/1090 | Rasagiline Mylan | Liechtenstein | 30.4.2016 |
EU/1/16/1090 | Rasagiline Mylan | Norwegia | 19.4.2016 |
EU/1/16/1090 | Rasagiline Mylan | Islandia | 22.4.2016 |
EU/1/16/1092 | Amlodipin/Valsartan Mylan | Liechtenstein | 30.4.2016 |
EU/1/16/1092 | Amlodipine/Valsartan Mylan | Norwegia | 11.4.2016 |
EU/1/16/1092 | Amlodipine/Valsartan Mylan | Islandia | 31.3.2016 |
EU/1/16/1093 | Zonisamide Mylan | Liechtenstein | 30.4.2016 |
EU/1/16/1093 | Zonisamide Mylan | Norwegia | 19.4.2016 |
EU/1/16/1093 | Zonisamide Mylan | Islandia | 22.4.2016 |
EU/1/16/1095 | IDELVION | Liechtenstein | 30.6.2016 |
EU/1/16/1095 | IDELVION | Norwegia | 30.5.2016 |
EU/1/16/1095 | IDELVION | Islandia | 23.5.2016 |
EU/1/16/1096 | Lonsurf | Liechtenstein | 30.4.2016 |
EU/1/16/1096 | Lonsurf | Norwegia | 9.5.2016 |
EU/1/16/1096 | LONSURF | Islandia | 20.5.2016 |
EU/1/16/1097 | Strimvelis | Liechtenstein | 30.6.2016 |
EU/1/16/1097 | Strimvelis | Norwegia | 9.6.2016 |
EU/1/16/1097 | Strimvelis | Islandia | 16.6.2016 |
EU/1/16/1098 | ALPROLIX | Liechtenstein | 30.6.2016 |
EU/1/16/1098 | Alprolix | Norwegia | 25.5.2016 |
EU/1/16/1098 | Alprolix | Islandia | 20.5.2016 |
EU/1/16/1099 | Descovy | Liechtenstein | 30.4.2016 |
EU/1/16/1099 | Descovy | Norwegia | 27.4.2016 |
EU/1/16/1099 | Descovy | Islandia | 18.5.2016 |
EU/1/16/1100 | Palonosetron Hospira | Liechtenstein | 30.4.2016 |
EU/1/16/1100 | Palonosetron Hospira | Norwegia | 19.4.2016 |
EU/1/16/1100 | Palonosetron Hospira | Islandia | 27.4.2016 |
EU/1/16/1101 | Darzalex | Liechtenstein | 30.6.2016 |
EU/1/16/1101 | Darzalex | Norwegia | 30.5.2016 |
EU/1/16/1101 | Darzalex | Islandia | 30.5.2016 |
EU/1/16/1103 | Neparvis | Liechtenstein | 30.6.2016 |
EU/1/16/1103 | Neparvis | Norwegia | 24.6.2016 |
EU/1/16/1104 | Palonosetron Accord | Liechtenstein | 30.6.2016 |
EU/1/16/1104 | Palonosteron Accord | Norwegia | 14.6.2016 |
EU/1/16/1104 | Palonosetron Accord | Islandia | 14.6.2016 |
EU/1/16/1106 | Flixabi | Liechtenstein | 30.6.2016 |
EU/1/16/1106 | Flixabi | Norwegia | 17.6.2016 |
EU/1/16/1106 | Flixabi | Islandia | 15.6.2016 |
EU/1/16/1109 | Zavicefta | Liechtenstein | 30.6.2016 |
EU/1/16/1112 | Odefsey | Liechtenstein | 30.6.2016 |
EU/1/16/1112 | Odefsey | Norwegia | 24.6.2016 |
EU/2/15/192 | Velactis | Norwegia | 4.1.2016 |
EU/2/15/193 | Imrestor | Norwegia | 5.1.2016 |
EU/2/15/193 | Imrestor | Islandia | 4.1.2016 |
EU/2/16/194 | Evalon | Liechtenstein | 30.4.2016 |
EU/2/16/194 | Evalon | Norwegia | 11.5.2016 |
EU/2/16/194 | Evalon | Islandia | 13.5.2016 |
EU/2/16/195 | LETIFEND | Liechtenstein | 30.4.2016 |
EU/2/16/195 | Letifend | Norwegia | 27.4.2016 |
EU/2/16/195 | Letifend | Islandia | 18.5.2016 |
ZAŁĄCZNIK II
Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data udzielenia zezwolenia |
EU/1/05/323 | ProQuad | Islandia | 4.1.2016 |
EU/1/05/323 | ProQuad | Norwegia | 11.1.2016 |
EU/1/05/330 | Rotarix | Liechtenstein | 29.2.2016 |
EU/1/05/330 | Rotarix | Islandia | 20.1.2016 |
EU/1/05/330 | Rotarix | Norwegia | 20.1.2016 |
EU/1/05/331 | Neupro | Liechtenstein | 29.2.2016 |
EU/1/05/331 | Neupro | Islandia | 28.1.2016 |
EU/1/05/331 | Neupro | Norwegia | 4.2.2016 |
EU/1/06/334 | Evoltra | Liechtenstein | 29.2.2016 |
EU/1/06/334 | Evoltra | Norwegia | 19.1.2016 |
EU/1/06/334 | Evoltra | Islandia | 20.1.2016 |
EU/1/06/336 | Tygacil | Liechtenstein | 29.2.2016 |
EU/1/06/336 | Tygacil | Norwegia | 18.3.2016 |
EU/1/06/336 | Tygacil | Islandia | 18.3.2016 |
EU/1/06/341 | Zostavax | Liechtenstein | 29.2.2016 |
EU/1/06/341 | Zostavax | Norwegia | 29.2.2016 |
EU/1/06/341 | Zostavax | Islandia | 18.2.2016 |
EU/1/06/346 | Tysabri | Norwegia | 29.4.2016 |
EU/1/06/346 | Tysabri | Islandia | 12.5.2016 |
EU/1/06/354 | Competact | Liechtenstein | 30.4.2016 |
EU/1/06/354 | Competact | Norwegia | 12.5.2016 |
EU/1/06/354 | Competact | Islandia | 18.5.2016 |
EU/1/06/356 | Exjade | Liechtenstein | 30.4.2016 |
EU/1/06/356 | Exjade | Norwegia | 2.5.2016 |
EU/1/06/356 | Exjade | Islandia | 12.5.2016 |
EU/1/09/543 | Cayston | Liechtenstein | 30.6.2016 |
EU/1/09/543 | Cayston | Norwegia | 14.6.2016 |
EU/1/09/543 | Cayston | Islandia | 13.6.2016 |
EU/1/10/652 | TOBI Podhaler | Liechtenstein | 29.2.2016 |
EU/1/10/652 | TOBI Podhaler | Norwegia | 1.3.2016 |
EU/1/10/652 | TOBI Podhaler | Islandia | 17.3.2016 |
EU/1/11/671 | Xiapex | Liechtenstein | 29.2.2016 |
EU/1/11/671 | Xiapex | Norwegia | 25.1.2016 |
EU/1/11/671 | Xiapex | Islandia | 27.1.2016 |
EU/1/11/672 | Xeplion | Norwegia | 11.1.2016 |
EU/1/11/672 | Xeplion | Islandia | 4.1.2016 |
EU/1/11/674 | Repso | Liechtenstein | 29.2.2016 |
EU/1/11/674 | Repso | Norwegia | 25.1.2016 |
EU/1/11/674 | Repso | Islandia | 20.1.2016 |
EU/1/11/679 | Pravafenix | Liechtenstein | 29.2.2016 |
EU/1/11/679 | Pravafenix | Norwegia | 2.2.2016 |
EU/1/11/679 | Pravafenix | Islandia | 26.1.2016 |
EU/1/11/681 | Trobalt | Liechtenstein | 29.2.2016 |
EU/1/11/681 | Trobalt | Norwegia | 25.1.2016 |
EU/1/11/681 | Trobalt | Islandia | 26.1.2016 |
EU/1/11/682 | Methylthioninium Chloride Proveblue | Norwegia | 29.2.2016 |
EU/1/11/682 | Methylthioninium chloride Proveblue | Islandia | 16.2.2016 |
EU/1/11/682 | Methylthioniniumchlorid Proveblue | Liechtenstein | 29.2.2016 |
EU/1/11/685 | Ibandronic acid Sandoz | Norwegia | 11.5.2016 |
EU/1/11/685 | Ibandronic acid Sandoz | Islandia | 27.4.2016 |
EU/1/11/687 | Hizentra | Liechtenstein | 29.2.2016 |
EU/1/11/687 | Hizentra | Norwegia | 29.2.2016 |
EU/1/11/687 | Hizentra | Islandia | 17.3.2016 |
EU/1/11/688 | Cinryze | Liechtenstein | 30.6.2016 |
EU/1/11/688 | Cinryze | Norwegia | 22.6.2016 |
EU/1/11/688 | Cinryze | Islandia | 13.6.2016 |
EU/1/11/690 | Zoely | Liechtenstein | 30.4.2016 |
EU/1/11/690 | Zoely | Norwegia | 29.4.2016 |
EU/1/11/690 | Zoely | Islandia | 18.5.2016 |
EU/1/11/691 | Eliquis | Liechtenstein | 29.2.2016 |
EU/1/11/691 | Eliquis | Norwegia | 2.2.2016 |
EU/1/11/691 | Eliquis | Islandia | 26.1.2016 |
EU/1/11/692 | Yellox | Liechtenstein | 29.2.2016 |
EU/1/11/692 | Yellox | Norwegia | 2.2.2016 |
EU/1/11/692 | Yellox | Islandia | 19.1.2016 |
EU/1/11/693 | Rivastigmin Actavis | Norwegia | 3.3.2016 |
EU/1/11/693 | Rivastigmine Actavis | Liechtenstein | 29.2.2016 |
EU/1/11/693 | Rivastigmine Actavis | Islandia | 15.3.2016 |
EU/1/11/694 | NULOJIX | Liechtenstein | 29.2.2016 |
EU/1/11/694 | NULOJIX | Norwegia | 26.2.2016 |
EU/1/11/694 | Nulojix | Islandia | 17.3.2016 |
EU/1/11/695 | Leganto | Liechtenstein | 29.2.2016 |
EU/1/11/695 | Leganto | Norwegia | 1.2.2016 |
EU/1/11/695 | Leganto | Islandia | 26.1.2016 |
EU/1/11/696 | BYDUREON | Liechtenstein | 29.2.2016 |
EU/1/11/696 | BYDUREON | Norwegia | 10.3.2016 |
EU/1/11/696 | Bydureon | Islandia | 17.3.2016 |
EU/1/11/697 | Temozolomide SUN | Liechtenstein | 30.4.2016 |
EU/1/11/697 | Temozolomide SUN | Norwegia | 29.4.2016 |
EU/1/11/697 | Temozolomide SUN | Islandia | 18.5.2016 |
EU/1/11/698 | Yervoy | Liechtenstein | 30.4.2016 |
EU/1/11/698 | Yervoy | Norwegia | 29.4.2016 |
EU/1/11/698 | Yervoy | Islandia | 18.5.2016 |
EU/1/11/699 | Fampyra | Liechtenstein | 30.6.2016 |
EU/1/11/699 | Fampyra | Islandia | 15.6.2016 |
EU/1/11/700 | Benlysta | Liechtenstein | 29.2.2016 |
EU/1/11/700 | Benlysta | Norwegia | 26.2.2016 |
EU/1/11/700 | Benlysta | Islandia | 18.3.2016 |
EU/1/11/702 | Levetiracetam ratiopharm | Liechtenstein | 30.4.2016 |
EU/1/11/702 | Levetiracetam ratiopharm | Norwegia | 18.5.2016 |
EU/1/11/702 | Levetiracetam ratiopharm | Islandia | 19.5.2016 |
EU/1/11/703 | Xgeva | Liechtenstein | 30.6.2016 |
EU/1/11/703 | XGEVA | Norwegia | 18.5.2016 |
EU/1/11/703 | XGEVA | Islandia | 13.5.2016 |
EU/1/11/704 | Victrelis | Liechtenstein | 29.2.2016 |
EU/1/11/704 | Victrelis | Islandia | 17.3.2016 |
EU/1/11/704 | Victrelis | Norwegia | 3.3.2016 |
EU/1/11/705 | Vibativ | Liechtenstein | 30.6.2016 |
EU/1/11/705 | Vibativ | Islandia | 13.6.2016 |
EU/1/11/705 | Vibativ | Norwegia | 9.6.2016 |
EU/1/11/706 | Levodopa/Carbidopa/Entacapone Orion | Liechtenstein | 30.6.2016 |
EU/1/11/706 | Levodopa/Carbidopa/Entacapone Orion | Islandia | 15.6.2016 |
EU/1/11/707 | Trajenta | Liechtenstein | 30.4.2016 |
EU/1/11/707 | Trajenta | Norwegia | 19.4.2016 |
EU/1/11/707 | Trajenta | Islandia | 31.3.2016 |
EU/1/11/708 | Entacapone Orion | Liechtenstein | 30.4.2016 |
EU/1/11/708 | Entacapone Orion | Norwegia | 21.4.2016 |
EU/1/11/708 | Entacapone Orion | Islandia | 26.4.2016 |
EU/1/11/709 | Buccolam | Liechtenstein | 30.6.2016 |
EU/1/11/709 | Buccolam | Norwegia | 24.6.2016 |
EU/1/11/709 | Buccolam | Islandia | 13.6.2016 |
EU/1/11/714 | Zytiga | Liechtenstein | 30.6.2016 |
EU/1/11/714 | Zytiga | Norwegia | 14.6.2016 |
EU/1/11/714 | Zytiga | Islandia | 13.6.2016 |
EU/1/11/718 | Dexdor | Liechtenstein | 30.6.2016 |
EU/1/11/718 | Dexdor | Norwegia | 20.6.2016 |
EU/1/11/718 | Dexdor | Islandia | 13.6.2016 |
EU/1/11/719 | Telmisartan Teva Pharma | Liechtenstein | 30.6.2016 |
EU/1/11/719 | Telmisartan Teva Pharma | Norwegia | 23.6.2016 |
EU/1/11/749 | Caprelsa | Norwegia | 14.1.2016 |
EU/1/11/749 | Caprelsa | Islandia | 14.1.2016 |
EU/1/12/764 | Pixuvri | Liechtenstein | 30.4.2016 |
EU/1/12/764 | Pixuvri | Norwegia | 1.4.2016 |
EU/1/12/764 | Pixuvri | Islandia | 31.3.2016 |
EU/1/13/818 | Bosulif | Norwegia | 14.1.2016 |
EU/1/13/818 | Bosulif | Islandia | 13.1.2016 |
EU/1/13/848 | Erivedge | Norwegia | 16.6.2016 |
EU/1/13/848 | Erivedge | Islandia | 15.6.2016 |
EU/1/13/875 | Deltyba | Norwegia | 29.3.2016 |
EU/1/13/875 | Deltyba | Islandia | 22.3.2016 |
EU/1/13/890 | Cometriq | Liechtenstein | 29.2.2016 |
EU/1/13/890 | Cometriq | Norwegia | 20.1.2016 |
EU/1/13/890 | Cometriq | Islandia | 19.1.2016 |
EU/1/13/901 | Sirturo | Liechtenstein | 29.2.2016 |
EU/1/13/901 | Sirturo | Norwegia | 14.1.2016 |
EU/1/13/901 | SIRTURO | Islandia | 13.1.2016 |
EU/1/14/987 | Holoclar | Islandia | 4.1.2016 |
EU/1/15/999 | Zykadia | Liechtenstein | 30.4.2016 |
EU/1/15/999 | Zykadia | Norwegia | 6.4.2016 |
EU/1/15/999 | Zykadia | Islandia | 31.3.2016 |
EU/2/06/061 | Nobilis Influenza H5N2 | Norwegia | 28.6.2016 |
EU/2/10/107 | Veraflox | Liechtenstein | 29.2.2016 |
EU/2/10/107 | Veraflox | Norwegia | 13.1.2016 |
EU/2/10/107 | Veraflox | Islandia | 15.1.2016 |
EU/2/10/115 | Comfortis | Liechtenstein | 29.2.2016 |
EU/2/10/115 | Comfortis | Norwegia | 18.1.2016 |
EU/2/10/115 | Comfortis | Islandia | 15.1.2016 |
EU/2/10/116 | Melosus | Liechtenstein | 29.2.2016 |
EU/2/10/116 | Melosus | Norwegia | 22.1.2016 |
EU/2/10/116 | Melosus | Islandia | 22.1.2016 |
EU/2/10/118 | Activyl | Liechtenstein | 29.2.2016 |
EU/2/10/118 | Activyl | Norwegia | 29.1.2016 |
EU/2/10/118 | Activyl | Islandia | 15.1.2016 |
EU/2/10/119 | Cimalgex | Liechtenstein | 29.2.2016 |
EU/2/10/119 | Cimalgex | Norwegia | 19.1.2016 |
EU/2/10/119 | Cimalgex | Islandia | 15.1.2016 |
EU/2/11/120 | Zulvac 1 + 8 Ovis | Liechtenstein | 29.2.2016 |
EU/2/11/120 | Zulvac 1 + 8 Ovis | Norwegia | 19.1.2016 |
EU/2/11/120 | Zulvac 1 + 8 Ovis | Islandia | 15.1.2016 |
EU/2/11/121 | CaniLeish | Liechtenstein | 29.2.2016 |
EU/2/11/121 | CaniLeish | Norwegia | 18.1.2016 |
EU/2/11/121 | CaniLeish | Islandia | 15.1.2016 |
EU/2/11/122 | BLUEVAC BTV8 | Liechtenstein | 30.4.2016 |
EU/2/11/122 | BLUEVAC BTV8 | Norwegia | 29.3.2016 |
EU/2/11/122 | Bluevac BTV8 | Islandia | 29.3.2016 |
EU/2/11/123 | Procox | Liechtenstein | 29.2.2016 |
EU/2/11/123 | Procox | Norwegia | 20.1.2016 |
EU/2/11/123 | Procox | Islandia | 20.1.2016 |
EU/2/11/124 | Zuprevo | Liechtenstein | 30.6.2016 |
EU/2/11/124 | Zuprevo | Norwegia | 1.6.2016 |
EU/2/11/124 | Zuprevo | Islandia | 26.5.2016 |
EU/2/11/125 | CERTIFECT | Liechtenstein | 30.4.2016 |
EU/2/11/125 | Certifect | Norwegia | 4.5.2016 |
EU/2/11/125 | Certifect | Islandia | 12.5.2016 |
EU/2/11/126 | MS-H Impfstoff | Liechtenstein | 30.6.2016 |
EU/2/11/126 | MS-H Vaccine | Islandia | 23.5.2016 |
EU/2/11/126 | MS-H-Vaksine | Norwegia | 24.5.2016 |
EU/2/11/128 | Emdocam | Liechtenstein | 30.6.2016 |
EU/2/11/128 | Emdocam | Norwegia | 27.6.2016 |
EU/2/11/129 | Proteq West Nile | Liechtenstein | 30.6.2016 |
EU/2/11/129 | Proteq West Nile | Norwegia | 24.5.2016 |
EU/2/11/129 | Proteq West Nile | Islandia | 23.5.2016 |
EU/2/11/130 | Zulvac 1 Bovis | Liechtenstein | 30.4.2016 |
EU/2/11/130 | Zulvac 1 Bovis | Norwegia | 2.5.2016 |
EU/2/11/130 | Zulvac 1 Bovis | Islandia | 13.5.2016 |
EU/2/11/131 | Zulvac 1 Ovis | Liechtenstein | 30.4.2016 |
EU/2/11/131 | Zulvac 1 Ovis | Norwegia | 2.5.2016 |
EU/2/11/131 | Zulvac 1 Ovis | Islandia | 13.5.2016 |
ZAŁĄCZNIK III
Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data udzielenia zezwolenia |
EU/1/03/262/011 | Emend | Norwegia | 15.1.2016 |
EU/1/03/262/011 | Emend | Islandia | 14.1.2016 |
EU/1/06/356/011-019 | Exjade | Norwegia | 1.4.2016 |
EU/1/06/356/011-019 | Exjade | Islandia | 31.3.2016 |
EU/1/10/612/010-013 | Revolade | Norwegia | 14.4.2016 |
EU/1/10/612/010-013 | Revolade | Islandia | 26.4.2016 |
EU/1/10/655/007-011 | Brilique | Norwegia | 26.2.2016 |
EU/1/10/655/007-011 | Brilique | Islandia | 18.3.2016 |
EU/1/13/851/004-006 | Lojuxta | Norwegia | 1.3.2016 |
EU/1/13/851/004-006 | Lojuxta | Islandia | 18.3.2016 |
EU/1/14/971/007-010 | Trevicta | Norwegia | 7.6.2016 |
EU/1/14/971/007-010 | TREVICTA | Islandia | 15.6.2016 |
EU/1/98/067/004 | Mabthera | Islandia | 15.6.2016 |
EU/1/98/067/004 | Mabthera | Norwegia | 26.5.2016 |
EU/2/13/158/016-031 | Bravecto | Norwegia | 7.6.2016 |
EU/2/13/158/016-031 | Bravecto | Islandia | 25.5.2016 |
ZAŁĄCZNIK IV
Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data wycofania |
EU/1/01/179 | Osigraft | Norwegia | 18.1.2016 |
EU/1/01/179 | Osigraft | Islandia | 4.1.2016 |
EU/1/05/314 | Kepivance | Liechtenstein | 30.4.2016 |
EU/1/05/314 | Kepivance | Islandia | 29.3.2016 |
EU/1/05/314 | Kepivance | Norwegia | 22.3.2016 |
EU/1/13/831 | Capecitabin SUN | Liechtenstein | 30.6.2016 |
EU/1/13/833 | Nuedexta | Liechtenstein | 30.4.2016 |
EU/1/13/833 | Nuedexta | Norwegia | 31.3.2016 |
EU/1/13/833 | NUEDEXTA | Islandia | 21.3.2016 |
EU/1/14/942 | Clopidogrel/Acetylsalicylic acid Teva | Norwegia | 15.6.2016 |
EU/2/12/138 | RevitaCAM | Liechtenstein | 30.6.2016 |
EU/2/12/138 | RevitaCAM | Norwegia | 15.6.2016 |
EU/2/12/138 | RevitaCAM | Islandia | 13.6.2016 |
ZAŁĄCZNIK V
Wykaz zawieszonych pozwoleń na dopuszczenie do obrotu
Wykaz zawieszonych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data zawieszenia |
© Unia Europejska, http://eur-lex.europa.eu/
Za autentyczne uważa się wyłącznie dokumenty Unii Europejskiej opublikowane w Dzienniku Urzędowym Unii Europejskiej.